A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Buprenorphine
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
 |
Wednesday, 6/5/2024 2:00 pm – 3:00 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
 |
Virtual event |
 |
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This training provides healthcare teams with information on available injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
|
Thursday, 7/25/2024 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudiencePhysicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend. |
Topic: Buprenorphine
This training provides healthcare teams with information on available injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
|
Tuesday, 9/17/2024 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudiencePhysicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend. |
Topic: Buprenorphine
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Wednesday, 10/16/2024 10:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Buprenorphine
This training provides healthcare teams with information on available injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
|
Thursday, 11/21/2024 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudiencePhysicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend. |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD).
|
Friday, 12/6/2024 1:00 pm – 3:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Buprenorphine
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Wednesday, 12/11/2024 9:00 am – 10:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders and nurses working in OTP, OBAT, primary care, inpatient, ED, etc |
Topic: Buprenorphine
This training provides healthcare teams with information on the available extended-release injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
|
Wednesday, 1/15/2025 9:00 am – 10:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudiencePhysicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction. |
Topic: Buprenorphine
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Thursday, 2/20/2025 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD). Participants will enhance their confidence in buprenorphine initiation through real-world case studies, exploring low-barrier models of care to improve access for individuals with OUD and strategies to reduce the risk of precipitated withdrawal.
|
Thursday, 2/27/2025 9:00 am – 11:00 am ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.